Newsroom

Industry News

30 Jul

GenSpera Inc. – “Why Partner: The Partnering Process – Part Two”

GenSpera Inc. (GNSZ) today published a new blog post on The Chairman’s Blog, written by the Company’s chief executive officer, Craig Dionne, Ph.D. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends. In the...

Read more

30 Jul

Insider Transaction: Mr. Leo Hindery Jr. Acquires Shares in MOKO Social Media

Media industry veteran and recently appointed MOKO Social Media Non-Executive Director, Mr. Leo Hindery Jr., has acquired 2,638,500 ASX listed shares (ASX: MKB) in MOKO Social Media. MOKO Social Media ADRs trade on the NASDAQ (NASDAQ: MOKO) on a 40:1 MKB:MOKO conversion — the acquisition representing a NASDAQ equivalent...

Read more

29 Jul

Inovio Pharmaceuticals’ DNA-Based Monoclonal Antibody Protects Animals Against Lethal Challenge

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that its DNA-based monoclonal antibody (dMAb) targeting dengue virus provided protection against a lethal dengue virus challenge in mice. A paper, “Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy,” was published inScientific Reports, a Nature Publishing Group journal. While conventional vaccine and...

Read more

28 Jul

OXiGENE to Host Second Quarter Financial Results Conference Call and Webcast

OXiGENE, Inc. (OXGN), a biopharmaceutical company developing novel therapies for treatment of cancer, today announced that the company will report second quarter 2015 financial results and provide a business update on Tuesday, August 4, 2015. The company’s management team will host a conference call and webcast at 4:30 p.m....

Read more

28 Jul

GenSpera Phase II Abstract Accepted for Presentation at the Society of Neuro-Oncology 20th Annual Scientific Meeting

GenSpera, Inc. (OTCQB: GNSZ) announced today that the Society for Neuro-Oncology and the 2015 Scientific Program Committee has accepted an abstract for presentation at the Society for Neuro-Oncology’s 20th Annual Scientific Meeting. The abstract is titled: “Phase II study of mipsagargin (G-202), a PSMA-activated prodrug targeting the tumor endothelium, in...

Read more

Page 1 of 8512345...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets